Technical Analysis for CTXR - Citius Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 1.39 6.92% 0.09
CTXR closed up 12.07 percent on Thursday, January 23, 2020, on 2.61 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical CTXR trend table...

Date Alert Name Type % Chg
Parabolic Rise Strength 6.92%
Wide Bands Range Expansion 6.92%
Above Upper BB Strength 6.92%
Upper Bollinger Band Touch Strength 6.92%
180 Bullish Setup Bullish Swing Setup 19.83%
Calm After Storm Range Contraction 19.83%
Wide Bands Range Expansion 19.83%
Parabolic Rise Strength 36.27%
Wide Bands Range Expansion 36.27%
Upper Bollinger Band Touch Strength 36.27%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care, and prescription products. Its product candidates include Mino-Lok and Hydrocortisone-Lidocaine Cream. The Company's Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. The Company's Hydrocortisone-Lidocaine topical formulation provides anti-inflammation and anesthetic relief to persons suffering from hemorrhoids. Its Mino-Lok product for the treatment of catheter related bloodstream infections has completed Phase IIb and is entering Phase III trials. It is reformulating Hydrocortisone-Lidocaine product and will be entering Phase IIb trials in 2017. As of September 30, 2016, the Company had not generate any revenues.
Medicine Medical Specialties Pharmaceutical Drugs Catheter Cancer Care Care Products Prescription Products Acetamides Lidocaine

Is CTXR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.59
52 Week Low 0.4
Average Volume 590,255
200-Day Moving Average 0.92
50-Day Moving Average 0.71
20-Day Moving Average 1.00
10-Day Moving Average 1.03
Average True Range 0.15
ADX 47.16
+DI 36.00
-DI 9.53
Chandelier Exit (Long, 3 ATRs ) 0.99
Chandelier Exit (Short, 3 ATRs ) 1.04
Upper Bollinger Band 1.25
Lower Bollinger Band 0.74
Percent B (%b) 1.09
BandWidth 51.41
MACD Line 0.12
MACD Signal Line 0.10
MACD Histogram 0.0208
Fundamentals Value
Market Cap 10.73 Million
Num Shares 8.25 Million
EPS -1.98
Price-to-Earnings (P/E) Ratio -0.66
Price-to-Sales 0.00
Price-to-Book 1.16
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.57
Resistance 3 (R3) 1.55 1.44 1.53
Resistance 2 (R2) 1.44 1.37 1.45 1.51
Resistance 1 (R1) 1.37 1.33 1.41 1.39 1.49
Pivot Point 1.26 1.26 1.28 1.27 1.26
Support 1 (S1) 1.19 1.19 1.23 1.21 1.11
Support 2 (S2) 1.08 1.15 1.09 1.09
Support 3 (S3) 1.01 1.08 1.08
Support 4 (S4) 1.03